Clinical trials
Withdrawn Migraine Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ache Laboratorios Farmaceuticos S.A. | 3 |
| NYU Langone Health | 3 |
| Allergan | 2 |
| Massachusetts Eye and Ear Infirmary | 2 |
| Mayo Clinic | 2 |
| Pfizer | 2 |
| United States Naval Medical Center, Portsmouth | 2 |
| Wake Forest University Health Sciences | 2 |
| Akron Children's Hospital | 1 |
| Allodynic Therapeutics, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 48 |
| Headache | 12 |
| Migraine with Aura | 4 |
| Dizziness | 3 |
| Emergencies | 3 |
| Migraine without Aura | 3 |
| Anxiety Disorders | 2 |
| Brain Injuries, Traumatic | 2 |
| Epilepsy | 2 |
| Headache Disorders, Primary | 2 |
Trials
Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.